These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34952462)

  • 1. Glutaredoxin 2 promotes SP-1-dependent CSPG4 transcription and migration of wound healing NG2 glia and glioma cells: Enzymatic Taoism.
    Wilms C; Lepka K; Häberlein F; Edwards S; Felsberg J; Pudelko L; Lindenberg TT; Poschmann G; Qin N; Volbracht K; Prozorovski T; Meuth SG; Kahlert UD; Remke M; Aktas O; Reifenberger G; Bräutigam L; Odermatt B; Berndt C
    Redox Biol; 2022 Feb; 49():102221. PubMed ID: 34952462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Significance of Chondroitin Sulfate Proteoglycan 4 (CSPG4) in Human Gliomas.
    Schiffer D; Mellai M; Boldorini R; Bisogno I; Grifoni S; Corona C; Bertero L; Cassoni P; Casalone C; Annovazzi L
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30213051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of chondroitin sulfate proteoglycan 4 (NG2/CSPG4) on soft-tissue sarcoma growth depend on tumor developmental stage.
    Hsu SC; Nadesan P; Puviindran V; Stallcup WB; Kirsch DG; Alman BA
    J Biol Chem; 2018 Feb; 293(7):2466-2475. PubMed ID: 29196603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NG2/CSPG4 and progranulin in the posttraumatic glial scar.
    Schäfer MKE; Tegeder I
    Matrix Biol; 2018 Aug; 68-69():571-588. PubMed ID: 29054751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Furanodienone overcomes temozolomide resistance in glioblastoma through the downregulation of CSPG4-Akt-ERK signalling by inhibiting EGR1-dependent transcription.
    Chen L; Liu YC; Zheng YY; Xu J; Zhang Y; Liu WL; Li ZY; Huang GD; Li WP
    Phytother Res; 2019 Jun; 33(6):1736-1747. PubMed ID: 31006910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chondroitin sulfate modification of CSPG4 regulates the maintenance and differentiation of glioma-initiating cells via integrin-associated signaling.
    Niibori-Nambu A; Yamasaki Y; Kobayashi D; Angata K; Kuno A; Panawan O; Silsirivanit A; Narimatsu H; Araki N
    J Biol Chem; 2024 Mar; 300(3):105706. PubMed ID: 38309500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diversified expression of NG2/CSPG4 isoforms in glioblastoma and human foetal brain identifies pericyte subsets.
    Girolamo F; Dallatomasina A; Rizzi M; Errede M; Wälchli T; Mucignat MT; Frei K; Roncali L; Perris R; Virgintino D
    PLoS One; 2013; 8(12):e84883. PubMed ID: 24386429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chondroitin Sulphate Proteoglycan 4 (NG2/CSPG4) Localization in Low- and High-Grade Gliomas.
    Mellai M; Annovazzi L; Bisogno I; Corona C; Crociara P; Iulini B; Cassoni P; Casalone C; Boldorini R; Schiffer D
    Cells; 2020 Jun; 9(6):. PubMed ID: 32599896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chondroitin sulfate proteoglycan protein is stimulated by interleukin 11 and promotes endometrial epithelial cancer cell proliferation and migration.
    Winship A; Van Sinderen M; Heffernan-Marks A; Dimitriadis E
    Int J Oncol; 2017 Mar; 50(3):798-804. PubMed ID: 28098860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NG2/CSPG4-collagen type VI interplays putatively involved in the microenvironmental control of tumour engraftment and local expansion.
    Cattaruzza S; Nicolosi PA; Braghetta P; Pazzaglia L; Benassi MS; Picci P; Lacrima K; Zanocco D; Rizzo E; Stallcup WB; Colombatti A; Perris R
    J Mol Cell Biol; 2013 Jun; 5(3):176-93. PubMed ID: 23559515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells.
    Cooney CA; Jousheghany F; Yao-Borengasser A; Phanavanh B; Gomes T; Kieber-Emmons AM; Siegel ER; Suva LJ; Ferrone S; Kieber-Emmons T; Monzavi-Karbassi B
    Breast Cancer Res; 2011 Jun; 13(3):R58. PubMed ID: 21658254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T lymphocytes redirected against the chondroitin sulfate proteoglycan-4 control the growth of multiple solid tumors both in vitro and in vivo.
    Geldres C; Savoldo B; Hoyos V; Caruana I; Zhang M; Yvon E; Del Vecchio M; Creighton CJ; Ittmann M; Ferrone S; Dotti G
    Clin Cancer Res; 2014 Feb; 20(4):962-71. PubMed ID: 24334762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zebrafish heart development is regulated via glutaredoxin 2 dependent migration and survival of neural crest cells.
    Berndt C; Poschmann G; Stühler K; Holmgren A; Bräutigam L
    Redox Biol; 2014; 2():673-8. PubMed ID: 24944912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel NG2-CreERT2 knock-in mice demonstrate heterogeneous differentiation potential of NG2 glia during development.
    Huang W; Zhao N; Bai X; Karram K; Trotter J; Goebbels S; Scheller A; Kirchhoff F
    Glia; 2014 Jun; 62(6):896-913. PubMed ID: 24578301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic relevance of NG2/CSPG4, CD44 and Ki-67 in patients with glioblastoma.
    Tsidulko AY; Kazanskaya GM; Kostromskaya DV; Aidagulova SV; Kiselev RS; Volkov AM; Kobozev VV; Gaitan AS; Krivoshapkin AL; Grigorieva EV
    Tumour Biol; 2017 Sep; 39(9):1010428317724282. PubMed ID: 28945172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional roles of CSPG4/NG2 in chondrosarcoma.
    Jamil NS; Azfer A; Worrell H; Salter DM
    Int J Exp Pathol; 2016 Apr; 97(2):178-86. PubMed ID: 27292772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural deciphering of the NG2/CSPG4 proteoglycan multifunctionality.
    Tamburini E; Dallatomasina A; Quartararo J; Cortelazzi B; Mangieri D; Lazzaretti M; Perris R
    FASEB J; 2019 Mar; 33(3):3112-3128. PubMed ID: 30550356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of chondroitin sulfate proteoglycan 4 (CSPG4) in melanoma cells is downregulated upon inhibition of BRAF.
    Uranowska K; Kalic T; Valtsanidis V; Kitzwögerer M; Breiteneder H; Hafner C
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The regulatory mechanisms of NG2/CSPG4 expression.
    Ampofo E; Schmitt BM; Menger MD; Laschke MW
    Cell Mol Biol Lett; 2017; 22():4. PubMed ID: 28536635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSPG4 as a target of antibody-based immunotherapy for malignant mesothelioma.
    Rivera Z; Ferrone S; Wang X; Jube S; Yang H; Pass HI; Kanodia S; Gaudino G; Carbone M
    Clin Cancer Res; 2012 Oct; 18(19):5352-63. PubMed ID: 22893632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.